OMNICELL, INC.OMCLEarnings & Financial Report
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.
OMCL Q3 2025 Key Financial Metrics
Revenue
$310.6M
Gross Profit
$134.5M
Operating Profit
$8.2M
Net Profit
$5.5M
Gross Margin
43.3%
Operating Margin
2.7%
Net Margin
1.8%
YoY Growth
10.0%
EPS
$0.12
Financial Flow
OMNICELL, INC. Q3 2025 Financial Summary
OMNICELL, INC. reported revenue of $310.6M for Q3 2025, with a net profit of $5.5M (1.8% margin). Cost of goods sold was $176.1M, operating expenses totaled $126.3M.
Key Financial Metrics
| Total Revenue | $310.6M |
|---|---|
| Net Profit | $5.5M |
| Gross Margin | 43.3% |
| Operating Margin | 2.7% |
| Report Period | Q3 2025 |
OMNICELL, INC. Annual Revenue by Year
OMNICELL, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $1.1B).
| Year | Annual Revenue |
|---|---|
| 2024 | $1.1B |
| 2023 | $1.1B |
| 2022 | $1.3B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $258.8M | $246.2M | $276.8M | $282.4M | $306.9M | $269.7M | $290.6M | $310.6M |
| YoY Growth | -13.0% | -15.3% | -7.4% | -5.4% | 18.6% | 9.6% | 5.0% | 10.0% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.23B | $2.28B | $2.29B | $2.30B | $2.12B | $2.15B | $2.15B | $1.95B |
| Liabilities | $1.04B | $1.10B | $1.09B | $1.07B | $877.6M | $894.4M | $881.9M | $727.7M |
| Equity | $1.19B | $1.19B | $1.20B | $1.23B | $1.24B | $1.26B | $1.26B | $1.22B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $38.4M | $50.0M | $58.7M | $22.8M | $56.3M | $25.9M | $42.8M | $28.3M |